Links Fore Leukemia Golf Tournament
The Leukemia & Lymphoma Society Golf Tournament has raised more than $2.68 million in the last 16 years to benefit The Leukemia & Lymphoma Society (LLS). The generosity of sponsors, golfers and other patrons has played a significant role in helping LLS in achieving its mission of curing leukemia, lymphoma, Hodgkin's disease and myeloma, and improving the quality of life of patients and their families.
MAKING A DIFFERENCE:
Since the tournament started more than 16 years ago, doctors have made life-changing break-throughs in blood cancer research. Below is a list of milestones that have been reached since Bob Barker and Jim Willis started the Links Fore Leukemia Golf Tournament:
The year the tournament started, LLS-funded researcher Brian Druker tested a drug directed at curing CML (chronic myelogenous leukemia). The drug, now called Gleevec, increased the five-year survival rate from 5% to 90%.
Since its approval by the FDA, Gleevac is now being tested for patients without blood cancers. Researchers hope it will help patients with breast, brain, lung, nerve, ovarian, prostate and thyroid cancers.
An LLS-funded researcher identified a chemical in a toe anti-fungal drug that is now in clinical trial to help AML (acute myeloid leukemia) patients.
LLS-funded researchers are now working towards what's considered the "holy grail" of blood cancer research - targeted therapies. The goal is to target the cancerous cells without impacting the healthy cells. LLS-funded researchers are making major strides that will not only save blood cancer patients lives but also improve the quality of their lives.
The good news is - the work is ongoing. Of 39 new cancer drugs approved by the F.D.A. since 2000, almost half (19) were approved as treatments for blood cancer patients, and many of these were advanced with LLS support.
Tanoan Country Club (View)
10801 Academy Rd NE
Albuquerque, NM 87111
|Kid Friendly: Yes!|
|Dog Friendly: No|
|Wheelchair Accessible: Yes!|